Multidisciplinary Hands-On Live Learning: Molecular Testing and Personalized Therapy in Lung Cancer - San Francisco, Calif.
Who should attend?
The program is open to physicians and allied health professionals that are involved in the care of patients with lung cancer. It is particularly suited for early career physicians and trainees.
- To understand the diagnostic work up and staging for patients with lung cancer
- To learn about the pathology and molecular pathology of lung cancer
- To discuss treatment approaches for patients with early stage lung cancer
- To understand the role of systemic therapy and targeted therapies for lung cancer
The program will provided a well rounded learning experience on lung cancer. The faculty will consist of renowned experts on various disciplines of lung cancer.
It is developed particularly for trainees and early career physicians that are involved in the care of lung cancer. The program will feature didactic lectures, hands-on training and case discussions that will help the attendee in gaining knowledge regarding the work up, staging, treatment and follow-up of patients with lung cancer. At the end of the program, the attendee will be able to gain in-depth understanding of key principles that drive the management of lung cancer.
- $25 for IASLC members
- $35 for non-IASLC members
Maximum 35 participants per meeting.
Location & Time:
Hotel Intercontinental San Francisco
888 Howard Street
San Francisco, CA 94103
December 4, 2015 8 a.m. - 4 p.m. - NEW DATE
Pathology: Fred R. Hirsch, MD, PhD, University of Colorado School of Medicine
Medical Oncology: Sai-Hong Ou, MD, PhD, University of California Irvine
Radiation Oncology: Bill Loo, MD, PhD, Stanford University
Pulmonology: Robert Keith, MD, University of Colorado
Surgery: Eric Vallieres, MD, Swedish Medical Center